213 related articles for article (PubMed ID: 2996763)
1. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
Yang L; Rowe TC; Liu LF
Cancer Res; 1985 Nov; 45(11 Pt 2):5872-6. PubMed ID: 2996763
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of epipodophyllotoxin-induced thymocyte apoptosis: possible role of a novel Ca(2+)-independent protein kinase.
Ye X; Georgoff I; Fleisher S; Coffman FD; Cohen S; Fresa KL
Cell Immunol; 1993 Oct; 151(2):320-35. PubMed ID: 8402939
[TBL] [Abstract][Full Text] [Related]
3. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
Ross W; Rowe T; Glisson B; Yalowich J; Liu L
Cancer Res; 1984 Dec; 44(12 Pt 1):5857-60. PubMed ID: 6094001
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
Hsiang YH; Jiang JB; Liu LF
Mol Pharmacol; 1989 Sep; 36(3):371-6. PubMed ID: 2550774
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
[TBL] [Abstract][Full Text] [Related]
6. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
7. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
Chen GL; Yang L; Rowe TC; Halligan BD; Tewey KM; Liu LF
J Biol Chem; 1984 Nov; 259(21):13560-6. PubMed ID: 6092381
[TBL] [Abstract][Full Text] [Related]
8. Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
Kerrigan D; Pommier Y; Kohn KW
NCI Monogr; 1987; (4):117-21. PubMed ID: 3041238
[TBL] [Abstract][Full Text] [Related]
9. DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.
Chow KC; Macdonald TL; Ross WE
Mol Pharmacol; 1988 Oct; 34(4):467-73. PubMed ID: 2845248
[TBL] [Abstract][Full Text] [Related]
10. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.
Hsiang YH; Liu LF
Cancer Res; 1988 Apr; 48(7):1722-6. PubMed ID: 2832051
[TBL] [Abstract][Full Text] [Related]
11. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
12. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
Rowe TC; Chen GL; Hsiang YH; Liu LF
Cancer Res; 1986 Apr; 46(4 Pt 2):2021-6. PubMed ID: 3004716
[TBL] [Abstract][Full Text] [Related]
13. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
Matsuo K; Kohno K; Takano H; Sato S; Kiue A; Kuwano M
Cancer Res; 1990 Sep; 50(18):5819-24. PubMed ID: 2168282
[TBL] [Abstract][Full Text] [Related]
14. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
Yang L; Rowe TC; Nelson EM; Liu LF
Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841
[TBL] [Abstract][Full Text] [Related]
15. Involvement of intracellular ATP in cytotoxicity of topoisomerase II-targetting antitumor drugs.
Kupfer G; Bodley AL; Liu LF
NCI Monogr; 1987; (4):37-40. PubMed ID: 2819729
[TBL] [Abstract][Full Text] [Related]
16. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
Pommier Y; Schwartz RE; Zwelling LA; Kerrigan D; Mattern MR; Charcosset JY; Jacquemin-Sablon A; Kohn KW
Cancer Res; 1986 Feb; 46(2):611-6. PubMed ID: 3000581
[TBL] [Abstract][Full Text] [Related]
17. Rational design and molecular effects of a new topoisomerase II inhibitor, azatoxin.
Leteurtre F; Madalengoitia J; Orr A; Guzi TJ; Lehnert E; Macdonald T; Pommier Y
Cancer Res; 1992 Aug; 52(16):4478-83. PubMed ID: 1322792
[TBL] [Abstract][Full Text] [Related]
18. Integration of simian virus 40 into cellular DNA occurs at or near topoisomerase II cleavage hot spots induced by VM-26 (teniposide).
Bodley AL; Huang HC; Yu C; Liu LF
Mol Cell Biol; 1993 Oct; 13(10):6190-200. PubMed ID: 8413219
[TBL] [Abstract][Full Text] [Related]
19. Induction of a heat-stable topoisomerase II-DNA cleavable complex by nonintercalative terpenoides, terpentecin and clerocidin.
Kawada S; Yamashita Y; Fujii N; Nakano H
Cancer Res; 1991 Jun; 51(11):2922-5. PubMed ID: 1851667
[TBL] [Abstract][Full Text] [Related]
20. Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
Hwang JL; Shyy SH; Chen AY; Juan CC; Whang-Peng J
Cancer Res; 1989 Feb; 49(4):958-62. PubMed ID: 2536295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
